1
|
Iwamura R, Tanaka M, Okanari E, Kirihara T, Odani-Kawabata N, Shams N, Yoneda K. Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl. J Med Chem 2018; 61:6869-6891. [DOI: 10.1021/acs.jmedchem.8b00808] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Ryo Iwamura
- Pharmaceuticals Research Laboratory, UBE Industries, Ltd., 1978-5 Kogushi, Ube, Yamaguchi 755-8633, Japan
| | - Masayuki Tanaka
- Pharmaceuticals Research Laboratory, UBE Industries, Ltd., 1978-5 Kogushi, Ube, Yamaguchi 755-8633, Japan
| | - Eiji Okanari
- Pharmaceuticals Research Laboratory, UBE Industries, Ltd., 1978-5 Kogushi, Ube, Yamaguchi 755-8633, Japan
| | - Tomoko Kirihara
- R&D Division, Santen Pharmaceutical Co., Ltd., Grand Front Osaka Tower A 4-20, Ofukacho, Kita-ku, Osaka 530-8552, Japan
| | - Noriko Odani-Kawabata
- R&D Division, Santen Pharmaceutical Co., Ltd., Grand Front Osaka Tower A 4-20, Ofukacho, Kita-ku, Osaka 530-8552, Japan
| | - Naveed Shams
- R&D Division, Santen Pharmaceutical Co., Ltd., Grand Front Osaka Tower A 4-20, Ofukacho, Kita-ku, Osaka 530-8552, Japan
- R&D Division, Santen Inc., 6401 Hollis Street, Suite 125, Emeryville, California 94608, United States
| | - Kenji Yoneda
- Pharmaceuticals Research Laboratory, UBE Industries, Ltd., 1978-5 Kogushi, Ube, Yamaguchi 755-8633, Japan
| |
Collapse
|
2
|
Das S, Chandrasekhar S, Yadav JS, Grée R. Recent developments in the synthesis of prostaglandins and analogues. Chem Rev 2007; 107:3286-337. [PMID: 17590055 DOI: 10.1021/cr068365a] [Citation(s) in RCA: 220] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Saibal Das
- Université de Rennes I, Laboratoire de Synthèse et Electrosynthèse Organiques, CNRS UMR 6510, Avenue du Général Leclerc, 35042 Rennes Cedex, France
| | | | | | | |
Collapse
|
3
|
Liang FS, Brik A, Lin YC, Elder JH, Wong CH. Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates. Bioorg Med Chem 2006; 14:1058-62. [PMID: 16275107 DOI: 10.1016/j.bmc.2005.09.026] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2005] [Revised: 09/09/2005] [Accepted: 09/09/2005] [Indexed: 11/30/2022]
Abstract
A method utilizing the strategy of epoxide opening by amine with water as co-solvent and screening in situ was developed for rapid discovery of protein inhibitors. Using this approach, HIV protease inhibitors with novel P1' residues were identified in our study. This strategy should be applicable for the efficient assembly of diverse compound collections for inhibitors' discovery and optimization in other systems.
Collapse
Affiliation(s)
- Fu-Sen Liang
- Department of Chemistry, The Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA
| | | | | | | | | |
Collapse
|
4
|
Wos JA, Lundy MW. Patent developments in anabolic agents for treatment of bone diseases. Expert Opin Ther Pat 2005. [DOI: 10.1517/13543776.13.8.1141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
5
|
Ebetino FH, Soper DL, Dirr MJ, Lundy MW, Mieling G, Wos JA, deLong MA, Liu X. The Rational Design of Drugs with Phos-phonic/phinic Acids as Enzyme Inhibitors Isosteric Receptor Ligands. PHOSPHORUS SULFUR 2002. [DOI: 10.1080/10426500212317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- Frank H. Ebetino
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| | - David L. Soper
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| | - Michelle J. Dirr
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| | - Mark W. Lundy
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| | - Glen Mieling
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| | - John A. Wos
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| | - Mitchell A. deLong
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| | - Xuewei Liu
- a Health Care Research Center , Procter & Gamble Pharmaceuticals , Mason , Ohio
| |
Collapse
|